Advisory and Governance

The Advisory and Governance team at XyloCor Therapeutics provides strategic oversight and expert guidance in the development of innovative gene therapies for cardiovascular diseases. Comprised of seasoned professionals with diverse backgrounds in medicine, biotechnology, and business leadership, the team ensures sound decision-making, regulatory compliance, and alignment with the company's mission to address significant patient needs. Their collective expertise drives both the research and operational strategies essential for advancing the company's therapeutic pipeline.